CSI Market
Sign In | Register

Allergan plc (AGN) Annual Balance Sheets

Annual · GAAP · USD millions
Access AGN quarterly Balance Sheets →
This page allows investors to track Allergan plc's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2019)
(Dec 31 2018) (Dec 31 2017) (Dec 31 2016) (Dec 31 2015)
Assets
Cash & cash equivalent2,503.30
Marketable Securities, Current SH3,411.60
Cash & Short-term Investments5,914.00
Accounts receivable3,192.30
Inventories1,133.10
Disposal Group, Including Discontinued Operation, Assets, Current AS0.00
Other current assets0.00
Deferred Tax Assets, Net of Valuation Allowance, Current0.00
Prepaid Expense And Other Assets Current886.40
Total Current Assets11,126.70
Equipment/Property/Plant Net1,926.50
Goodwill net42,248.30
Intangible Assets37,890.60
Long-term investments408.00
Deferred Tax Assets, Net of Valuation Allowance, Noncurrent576.90
Other Assets522.10
Long Term Assets Held For Sale Relating To Discontinued Operations0.00
Total Assets94,699.10
Liabilities
Accounts Payable and Accrued Liabilities, Current LI6,348.70
Long-term Debt, Current Maturities LO4,532.50
Other current liabilities124.40
Accrued Income Taxes, Current TA65.10
Total Current Liabilities11,070.70
Long-term debt18,116.50
Total Long-term Debt18,116.50
Deferred Tax Liabilities, Net, Noncurrent LI4,363.70
Disposal Group, Including Discontinued Operation, Liabilities LI0.00
Other longterm liabilities2,951.80
Other Taxes Payable Including Uncertain Positions Noncurrent0.00
Total Liabilities36,502.70
Stockholders' Equity
Preferred Share Value-
Additional Paid In Capital Common Stock55,974.90
Retained Earnings / Accumulated Deficit991.50
Other Equity-54,639.10
Common Stockholder's Equity2,327.30
Non-controlling interests & other55,869.10
Total Stockholder's Equity58,196.40
Liabilities & Stockholder's Equity94,699.10
4 historic quarters locked

Sign in to unlock the full Allergan plc balance sheet history.

Sign In Create Free Account

About AGN Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License